Olivier Benveniste

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 271 publications

Inclusion body myositis: new insights into pathogenesis and therapeutic perspectives.

Inclusion body myositis: new insights into pathogenesis and therapeutic perspectives.

Journal: Current opinion in rheumatology

Published: September 02, 2026

Rapid efficacy of anifrolumab in refractory cutaneous dermatomyositis.

Rapid efficacy of anifrolumab in refractory cutaneous dermatomyositis.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: May 22, 2026

Inflammatory Myopathies.

Inflammatory Myopathies.

Journal: The New England journal of medicine

Published: May 13, 2026

Characteristics and outcomes of anti-Ku antibody-associated interstitial lung disease: a retrospective study of 60 patients.

Characteristics and outcomes of anti-Ku antibody-associated interstitial lung disease: a retrospective study of 60 patients.

Journal: RMD open

Published: March 14, 2026

Inflammation reprograms fibro-adipogenic progenitors to sustain immunopathogenic niches in myositis.

Inflammation reprograms fibro-adipogenic progenitors to sustain immunopathogenic niches in myositis.

Journal: Cell death & disease

Published: February 09, 2026

Drug-induced autophagic myopathies: Exploring pathophysiology with immunolabelling and proteomics.

Drug-induced autophagic myopathies: Exploring pathophysiology with immunolabelling and proteomics.

Journal: Journal of neuropathology and experimental neurology

Published: January 29, 2026

Multiparametric assessment of the MyoSuit, a bi-articular exoskeleton designed to assist gait and transfers in adults with neuromuscular diseases.

Multiparametric assessment of the MyoSuit, a bi-articular exoskeleton designed to assist gait and transfers in adults with neuromuscular diseases.

Journal: Journal of neuromuscular diseases

Published: January 08, 2026

Comment on: Eculizumab as rescue therapy in refractory anti-NXP2 dermatomyositis with digestive vasculitis and gastrointestinal perforation: report of two case: Reply.

Comment on: Eculizumab as rescue therapy in refractory anti-NXP2 dermatomyositis with digestive vasculitis and gastrointestinal perforation: report of two case: Reply.

Journal: Rheumatology (Oxford, England)

Published: December 18, 2025

Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome Measures.

Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome Measures.

Journal: Arthritis care & research

Published: December 08, 2025

Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome Measures.

Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome Measures.

Journal: Arthritis care & research

Published: December 08, 2025

Spontaneous remission in statin-associated HMGCR-positive immune-mediated necrotizing myopathy after statin withdrawal.

Spontaneous remission in statin-associated HMGCR-positive immune-mediated necrotizing myopathy after statin withdrawal.

Journal: Neuromuscular disorders : NMD

Published: December 05, 2025

AI-based chest CT quantification of interstitial lung disease in idiopathic inflammatory myopathies: agreement with expert visual assessment in 107 patients.

AI-based chest CT quantification of interstitial lung disease in idiopathic inflammatory myopathies: agreement with expert visual assessment in 107 patients.

Journal: BMC pulmonary medicine

Published: November 30, 2025

Showing 1-12 of 271

Last Updated: 09/26/2026